rs1428102803

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NR_120364.1(CASC19):​n.153+3842C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00484 in 151,392 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.0048 ( 2 hom., cov: 30)

Consequence

CASC19
NR_120364.1 intron

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -1.89

Publications

1 publications found
Variant links:
Genes affected
CASC19 (HGNC:49476): (cancer susceptibility 19)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BS2
High Homozygotes in GnomAd4 at 2 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NR_120364.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASC19
NR_120364.1
n.153+3842C>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASC19
ENST00000641001.1
n.324-5518C>A
intron
N/A
CASC19
ENST00000641013.1
n.256-5518C>A
intron
N/A
CASC19
ENST00000641029.1
n.219-3651C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00484
AC:
732
AN:
151278
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00145
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000582
Gnomad SAS
AF:
0.00229
Gnomad FIN
AF:
0.0145
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00730
Gnomad OTH
AF:
0.00145
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00484
AC:
732
AN:
151392
Hom.:
2
Cov.:
30
AF XY:
0.00507
AC XY:
375
AN XY:
73940
show subpopulations
African (AFR)
AF:
0.00109
AC:
45
AN:
41312
American (AMR)
AF:
0.00145
AC:
22
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.000583
AC:
3
AN:
5144
South Asian (SAS)
AF:
0.00229
AC:
11
AN:
4802
European-Finnish (FIN)
AF:
0.0145
AC:
153
AN:
10556
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00731
AC:
494
AN:
67618
Other (OTH)
AF:
0.00143
AC:
3
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.414
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00674
Hom.:
0

ClinVar

ClinVar submissions
Significance:association
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Familial prostate cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.36
DANN
Benign
0.28
PhyloP100
-1.9

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1428102803; hg19: chr8-128205878; API